New heart device aims to make key procedure safer and easier

NCT ID NCT07361445

Recruiting now Disease control Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Jan 23, 2026 · Last updated May 16, 2026 · Updated 17 times

Summary

This early study tests a new tool called the Agilis RF Transseptal System, which uses radiofrequency energy to safely cross the wall between the upper chambers of the heart. The goal is to help doctors access the left side of the heart during treatments for heart rhythm issues or to close the left atrial appendage. The study will enroll 20 adults and follow them only until they leave the hospital.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARRYTHMIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Arrhythmia Research Group (St. Bernards)
RECRUITING

Jonesboro, Arkansas, 72401, United States
California Pacific Medical Center -Van Ness Campus
RECRUITING

San Francisco, California, 94109, United States

Conditions

Explore the condition pages connected to this study.

CARDIAC ARRYTHMIAS LEFT ATRIAL APPENDAGE CLOSURE